ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Stem Cells & Wnt >Hedgehog / Smoothened inhibitor >Glasdegib

Glasdegib

Glasdegib Structure
CAS No.
1095173-27-5
Chemical Name:
Glasdegib
Synonyms
CS-1041;EOS-60832;Glasdegib;PF 04449913;Glasdegib-D3;Glasdegib-D4;Glasdegib-13C6;Glasdegib-13C,15N;Glasdegib USP/EP/BP;PF04449913; PF 04449913
CBNumber:
CB82658197
Molecular Formula:
C21H22N6O
Molecular Weight:
374.44
MOL File:
1095173-27-5.mol
Modify Date:
2023/12/28 17:21:45

Glasdegib Properties

Melting point >214°C (dec.)
Boiling point 633.4±55.0 °C(Predicted)
Density 1.33±0.1 g/cm3(Predicted)
storage temp. -20°C Freezer
solubility DMSO (Slightly), Methanol (Slightly)
form Solid
pka 11.93±0.10(Predicted)
color Off-White
InChIKey SFNSLLSYNZWZQG-VQIMIIECSA-N
SMILES N([C@@H]1CCN(C)[C@@H](C2NC3=CC=CC=C3N=2)C1)C(NC1=CC=C(C#N)C=C1)=O

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS08
Signal word  Warning
Hazard statements  H361-H373
Precautionary statements  P201-P202-P281-P308+P313-P405-P501-P260-P314-P501

Glasdegib Chemical Properties,Uses,Production

Uses

Glasdegib acts as a potent, orally biovailablesmoothened (Smo) inhibitor used in the treatment of cancer.

Biochem/physiol Actions

PF-04449913 maleate salt is also known as 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea. It increases the differentiation of blood cells from hematopoietic precursors of the lymph gland medullary zone. This human Smo inhibitor protein is now under clinical trials to treat myeloid malignancies.
PF-04449913 (Glasdegib) is an orally bioavailable Hedgehog pathway inhibitor. PF-04449913 acts by binidng Smoothened (Smo) and blocking signal transduction. PF-04449913 has an IC50 of 5 nM in the Gli-Luciferase assay. In a Phase I clinical trial in patients with advanced solid tumors, PF-04449913 caused disease stabilization in 34% of patients.

Glasdegib Suppliers

Global( 121)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
Suzhou Ryan Pharmachem Technology Co.,Ltd. +86-512-68780025 +8618962125825 China 137 58 Inquiry
Jinan Carbotang Biotech Co.,Ltd. +8615866703830 China 7287 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29826 58 Inquiry
Career Henan Chemica Co +86-0371-86658258 +8613203830695 China 30253 58 Inquiry
ANHUI WITOP BIOTECH CO., LTD +8615255079626 China 23556 58 Inquiry

Related articles

  • How to synthesize Glasdegib?
  • Glasdegib was approved in 2018 for the treatment of newly diagnosed acute myeloid leukemia (AML) patients at least 75 years of....
  • Dec 28,2023

Glasdegib Spectrum

PF 04449913 1-((2R,4R)-2-(1H-benzo[d]iMidazol-2-yl)-1-Methylpiperidin-4-yl)-3-(4-cyanophenyl)urea N-[(2R,4R)-2-(1H-Benzimidazol-2-yl)-1-methyl-4-piperidinyl]-N'-(4-cyanophenyl)urea Glasdegib (PF-04449913) N-[(2R,4R)-2-(1H-Benzimidazol-2-yl)-1-methyl-4-piperidinyl]-N'-(4-cyanophenyl)urea PF 04449913 Glasdegib EOS-60832 CS-1041 PF-04449913 (Glasdegib) PF04449913; PF 04449913 Urea, N-[(2R,4R)-2-(1H-benzimidazol-2-yl)-1-methyl-4-piperidinyl]-N'-(4-cyanophenyl)- Glasdegib USP/EP/BP Glasdegib-13C,15N Glasdegib-13C6 Glasdegib-D3 Glasdegib-D4 1095173-27-5 Inhibitors